Here are the 8-K filings from Shorepower Technologies (SPEV) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow SPEV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SPEV filings page.
Shorepower Technologies has agreed to merge with Aeternum Health LLC, with Aeternum merging into Shorepower and Shorepower surviving. At closing, Paul Mann will receive Shorepower common shares equal to 51% of the company and 2,000,000 Series B preferred shares, each carrying the voting power of 40 common shares, giving him control. Jeff Kim will resign as officer and sole director, appoint Mann as President, CEO and sole director, and ultimately cancel 13,000,000 of his Shorepower common shares in stages linked to additional healthcare mergers. The company will spin out its transportation electrification assets, change its name to Aeternum Health Inc., seek a new trading symbol, and increase authorized common shares from 100 million to 250 million. Aeternum will contribute at least $1.5 million in cash plus know-how, data, related IP and a business focused on a novel peptide mix for longevity and anti-aging, subject to customary closing conditions including delivery of audited financial statements.